KLOW 80mg

KLOW is a single-vial research blend combining four peptides in one preparation: KPV, a Lys-Pro-Val tripeptide; BPC-157, a pentadecapeptide; TB-500, a thymosin beta-4 fragment; and GHK-Cu, a copper-binding tripeptide. The vial holds 80mg of total peptide content. It is supplied to laboratories as a ready-mixed combination rather than as four separate single-compound vials, keeping the components together in one consistently prepared sample.

Each component belongs to a distinct peptide class. KPV is investigated in anti-inflammatory research, while BPC-157 features in tissue-repair research literature. TB-500, a fragment of thymosin beta-4, is studied for its role in cell-migration research, and GHK-Cu is examined in collagen research owing to its copper-binding structure. Together they represent four mechanistically separate research targets held within a single vial.

KLOW UK is offered because these four peptides are frequently examined together as a combined tissue-repair research preparation. Grouping compounds studied around inflammation, repair, migration and collagen pathways lets researchers observe their behaviour side by side within one consistently prepared sample. This combined format suits comparative laboratory work where several mechanisms of interest are investigated in parallel rather than in isolation.

Each component in KLOW is analysed by reverse-phase HPLC and ESI mass spectrometry, with a batch-linked Certificate of Analysis available for the finished blend. It is supplied lyophilised and should be stored sealed, away from light, heat and moisture, with cold storage recommended after reconstitution. It is sourced and handled in the UK. This product is sold strictly for laboratory research use only.